What is a genicular nerve block injection?

What is a Genicular Nerve Block Injection?

A genicular nerve block injection is a minimally invasive procedure that delivers local anesthetic (with or without corticosteroid) around the sensory nerve branches that innervate the knee joint capsule and ligaments, primarily used to manage chronic knee pain from osteoarthritis. 1, 2

Anatomical Targets and Technique

The procedure targets three primary genicular nerve branches that provide sensory innervation to the knee joint:

• Superior lateral genicular nerve - located at the junction of the femoral shaft and lateral epicondyle 3
• Superior medial genicular nerve - positioned at the junction of the femoral shaft and medial epicondyle 3
• Inferior medial genicular nerve - found at the junction of the tibial shaft and medial tibial plateau 3

The injection is performed extra-articularly (outside the joint space), distinguishing it from intra-articular knee injections. 3 Image guidance using either fluoroscopy or ultrasound is employed to ensure accurate needle placement around these nerve branches. 1, 2

Clinical Applications

Diagnostic vs. Therapeutic Use

Diagnostic blocks use local anesthetic only (typically 1 mL of 1% lidocaine per site) to determine if knee pain originates from structures innervated by genicular nerves. 3 A positive response (≥50% pain reduction lasting at least 6 hours to 24 hours) traditionally indicated candidacy for subsequent radiofrequency ablation, though recent evidence questions the predictive value of this approach. 1

Therapeutic blocks combine local anesthetic with corticosteroid (commonly 2 mL mixture of 1% lidocaine plus 20 mg triamcinolone per site) to provide longer-lasting pain relief. 4 These injections can provide pain relief ranging from one week to several months in patients with knee osteoarthritis. 5, 4

Patient Selection Criteria

Genicular nerve blocks are reserved for patients with symptomatic knee osteoarthritis who meet specific criteria:

• Failed conservative management including weight loss, physical therapy, bracing, NSAIDs, and potentially intra-articular therapies 3
• Poor surgical candidates or those who have declined total knee replacement 3
• Chronic knee pain (typically >3 months duration) that causes functional limitation 5, 2

The procedure has demonstrated utility even in acute exacerbations, with one case report showing one week of relief in an emergency department setting for acute-on-chronic osteoarthritic knee pain. 5

Clinical Outcomes and Evidence

Pain Relief Duration

Therapeutic genicular nerve blocks with corticosteroid provide variable pain relief:

• Short-term relief (1 hour to 24 hours): Nearly universal immediate pain reduction, with revised anatomical targets showing 100% response rate at 1 hour post-injection 4
• Medium-term relief (1-12 weeks): Significant pain reduction and functional improvement maintained up to 12 weeks, though individual response varies 4
• Repeated injections: Patients commonly report 2-3 months of relief per injection, requiring repeat procedures 6

Functional Improvements

Beyond pain scores, genicular nerve blocks demonstrate improvements in validated functional measures:

• Oxford Knee Score (OKS) and WOMAC scores show significant improvement up to 12 weeks post-injection 4
• Motor function preservation: Unlike femoral nerve blocks, genicular blocks provide sensory analgesia without motor compromise, allowing immediate weight-bearing and ambulation 2

Technical Considerations and Pitfalls

Volume and Spread

The volume of injectate significantly impacts outcomes. While diagnostic blocks use 1 mL per site, therapeutic blocks often use 2 mL per site. 4, 3 Larger volumes may compensate for less precise needle placement by allowing greater spread around target nerves, potentially explaining why classical anatomical targets (despite being less precise) achieve similar long-term outcomes to revised targets. 4

Anatomical Target Precision

Recent evidence comparing classical versus revised anatomical targets revealed that while revised targets produced superior immediate pain relief (100% vs 82.1% achieving >50% reduction at 1 hour), both techniques yielded equivalent outcomes at 4 and 12 weeks. 4 This suggests the large injection volume creates a "field block" effect that mitigates the importance of precise needle placement for therapeutic (but not diagnostic) blocks.

Common Pitfalls to Avoid

• Confusing with intra-articular injections: Genicular nerve blocks are extra-articular procedures targeting nerves, not the joint space itself 3
• Using as sole long-term treatment: The procedure should be part of comprehensive pain management, not a standalone intervention 6
• Inadequate conservative treatment first: Performing blocks without documented failure of physical therapy, NSAIDs, and other conservative measures violates standard care principles 3
• Inappropriate use for non-osteoarthritic pain: The procedure specifically targets osteoarthritic knee pain, not other knee pathologies 2, 3

Safety Profile

Genicular nerve blocks are generally well-tolerated with minimal adverse events:

• No motor blockade: Preserved quadriceps function allows immediate ambulation without fall risk 2
• Office-based procedure: Can be performed under local anesthesia without sedation, though anxious patients may receive low-dose midazolam 3
• No Charcot joint development: Despite theoretical concerns about joint denervation, no cases have been reported, as the deafferentation is only partial 3
• Corticosteroid-related effects: Standard systemic corticosteroid risks apply (hyperglycemia, immunosuppression, bone density effects) though local injection minimizes systemic exposure 7

Relationship to Radiofrequency Ablation

Genicular nerve blocks serve as the diagnostic precursor to genicular nerve radiofrequency ablation (GNRFA), a more definitive treatment. However, the predictive value of diagnostic blocks remains controversial. One randomized trial found that prognostic blocks using ≥50% pain relief as a threshold did not improve the success rate of subsequent cooled radiofrequency ablation (58.6% vs 64.0% success without prognostic block). 1 This challenges the traditional two-step paradigm and suggests patient selection criteria beyond diagnostic block response may be needed.